News
Article
Author(s):
In case you missed it, this week we had news about Oleogel-10's potential in dressing changes for pediatric patients with epidermolysis bullosa, data for repigmentation with ruxolitinib cream, a review of pediatric cutaneous Crohn disease, and more.
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.
Oleogel-10 exhibited potential to alleviate the physical, emotional, and economic strain of dressing changes, according to a poster presented at the SPD's annual meeting.
Smidt and Hunt offer insights on navigating pediatric dermatology decision-making, emphasizing learning from clinical scenarios and fostering a culture of feedback and improvement.
Metz and Tollefson share insights on efficient practice management, work-life balance, and exciting developments in pediatric dermatology.
The AICHI study found a significant prevalence of severe primary axillary hyperhidrosis in children in Japan, according to a poster presented at the SPD's annual meeting.
Catch up on coverage from the 2024 Society for Pediatric Dermatology Annual Meeting in Toronto, Ontario, Canada.
Rick Guidotti, fashion photographer turned patient advocate, discusses reframing beauty through his nonprofit Positive Exposure.
Jenny Murase, MD, and Elizabeth Kiracofe, MD, highlighted key clinical considerations to optimize atopic dermatitis care for patients during pregnancy, prepregnancy, postpartum, and breastfeeding.
Mona Shahriari, MD, hosted a Case-Based Roundtable discussion to review 2 challenging cases of atopic dermatitis in patients with skin of color.
David Rosmarin, MD, shared his insights on the study in a Q&A with Dermatology Times.
Adhering to a Mediterranean diet and incorporating omega-3 supplements led to noticeable improvements in acne severity, reducing both inflammatory and non-inflammatory lesions in patients.
Ben Lockshin, MD, FAAD, shared his insights on the latest advancements in oral options for psoriasis therapies.
This week’s collection of the latest dermatologic studies includes drug-induced epidermal necrolysis in pediatric patients, predicting relapse in chronic spontaneous urticaria, fatigue in patients with psoriasis and psoriatic arthritis, and the role of eosinophils in hidradenitis suppurativa.
The increasing prevalence of this chronic condition in children necessitates understanding its broader impacts and management strategies.
Researchers behind the latest benzene studies found no increased cancer risk with use of products containing benzoyl peroxide.
Diamant Thaçi, MD, PhD, shares insights on the data presented at the World Psoriasis & Psoriatic Arthritis (IFPA) Conference.
Zoe Diana Draelos, MD, examines common questions and controversies regarding physiologic differences in skin between White, African American, and Hispanic individuals.
Researchers said individuals with vitiligo should monitor for RA and SLE, as regular check-ups are essential for managing this risk.
A recent study found that patients with genital psoriasis involvement are more likely to have involvement in other special body areas, such as the scalp.
Michelle Bolas and Rukiyah T. Van Dross-Anderson, PhD, discuss the significance of NCInnovations’ funding and the clinical impact of Van Dross-Anderson's research in patients with advanced melanoma.
In a milestone year for Dermatology Times, our Editorial Advisory Board reflects on how patient interactions have changed over time.
Four APPs emphasized the vital role of advanced practice providers in improving patient care and expanding service access.
A recent case series reviewed the treatment patterns and effects of therapies on 89 pediatric patients with CCD.
A recent study found that pharmacy professionals had an increased level of capability, opportunity, and motivation after accessing the resource.
The study saw a reduction of 2 major UVA-induced mtDNA deletions associated with skin photoaging.
Linda Stein Gold, MD, reviews data presented at SPD and elaborates on study design, methodology, and results.